Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases

• 作者: Zixin Shu Yana Zhou Kai Chang Jifen Liu Xiaojun Min Qing Zhang Jing Sun Yajuan Xiong Qunsheng Zou Qiguang Zheng Jinghui Ji Josiah Poon Baoyan Liu Xuezhong Zhou Xiaodong Li
• 来源期刊: 医学前沿
• 年，卷（期）: 2020,（6）
• 所属期刊栏目: Research Articles
• 页码范围: 760-775
• 页数: 16页
• 语种: 英文

摘要

Coronavirus disease 2019 (COVID-19) is now pandemic worldwide and has heavily overloaded hospitals in Wuhan City,China during the time between late January and February.We reported the clinical features and therapeutic characteristics of moderate COVID-19 cases in Wuhan that were treated via the integration of traditional Chinese medicine (TCM) and Western medicine.We collected electronic medical record(EMR) data,which included the full clinical profiles of patients,from a designated TCM hospital in Wuhan.The structured data of symptoms and drugs from admission notes were obtained through an information extraction process.Other key clinical entities were also confirmed and normalized to obtain information on the diagnosis,clinical treatments,laboratory tests,and outcomes of the patients.A total of 293 COVID-19 inpatient cases,including 207 moderate and 86 (29.3％) severe cases,were included in our research.Among these cases,238 were discharged,31 were transferred,and 24 (all severe cases) died in the hospital.Our COVID-19 cases involved elderly patients with advanced ages (57 years on average) and high comorbidity rates (61％).Our results reconfirmed several well-recognized risk factors,such as age,gender (male),and comorbidities,as well as provided novel laboratory indications (e.g.,cholesterol) and TCM-specific phenotype markers (e.g.,dull tongue) that were relevant to COVID-19 infections and prognosis.In addition to antiviral/antibiotics and standard supportive therapies,TCM herbal prescriptions incorporating 290 distinct herbs were used in 273 (93％) cases.The cases that received TCM treatment had lower death rates than those that did not receive TCM treatment (17/273 = 6.2％ vs.7/20 = 35％,P = 0.0004 for all cases;17/77 = 22％ vs.7/9 = 77.7％,P = 0.002 for severe cases).The TCM herbal prescriptions used for the treatment of COVID-19 infections mainly consisted of Pericarpium Citri Reticulatae,Radix Scutellariae,Rhizoma Pinellia,and their combinations,which reflected the practical TCM principles (e.g.,clearing heat and dampening phlegm).Lastly,59％ of the patients received treatment,including antiviral,antibiotics,and Chinese patent medicine,before admission.This situation might have some effects on symptoms,such as fever and dry cough.By using EMR data,we described the clinical features and therapeutic characteristics of 293 COVID-19 cases treated via the integration of TCM herbal prescriptions and Western medicine.Clinical manifestations and treatments before admission and in the hospital were investigated.Our results preliminarily showed the potential effectiveness of TCM herbal prescriptions and their regularities in COVID-19 treatment.